Actively Recruiting
Evaluation of Emergency Medicine Pharmacist Impact on Blood Culture Review Following Emergency Department Discharge
Led by Methodist Health System · Updated on 2026-03-20
126
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying the impact of emergency medicine pharmacists (EMPs) on reviewing blood culture results for patients discharged from the Emergency Department (ED) who have pending blood cultures. The study aims to evaluate if pharmacists, compared to charge nurses and physicians, improve the speed and appropriateness of notifications and antibiotic therapy for positive blood cultures. This observational research is motivated by the critical role pharmacists play in improving medication safety and reducing complications such as sepsis and septic shock. The study compares two groups: one where EMPs review and act on blood cultures using collaborative practice agreements, and another where charge nurses and physicians handle the reviews. Data will be collected retrospectively from electronic medical records at two medical centers, covering patients discharged with pending blood cultures between July 2022 and July 2023. The data collection will begin after institutional approval is obtained. Participants' medical records will be reviewed for timing of blood culture review and patient notification after a positive result. Researchers will also examine the appropriateness of antibiotic selection upon patient return, reasons for return visits, and rates of unnecessary callbacks or admissions. The primary outcome measures the time from positive culture to review and notification over an 18-month period. This study involves no direct intervention and monitors standard care processes in an observational manner.
CONDITIONS
Brief Title
Evaluation of Emergency Medicine Pharmacist Impact on Blood Culture Review Following Emergency Department Discharge
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with a positive blood culture result collected during the initial Emergency Department visit
- Patients discharged from the Emergency Department to outpatient or long-term care before critical blood culture results were available
You will not qualify if you...
- Patients admitted as inpatients after the Emergency Department visit
- Patients transferred from the Emergency Department to another acute care facility
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or via medical record review)
Duration - Up to 12 months of retrospective data collection
Participants who were discharged from the Emergency Department with pending blood culture results are observed through their medical records to evaluate the time to review and notification of positive blood cultures and related outcomes.
No in-person visits; data collected from electronic medical records
Trial Site Locations
Total: 1 location
1
Clinical Research Institute Methodist Health System
Dallas, Texas, United States, 75203
Actively Recruiting
Research Team
C
Crystee Cooper, DHEd
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here